Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
- Authors
- Kim, H.R.; Lee, Y.S.; Yim, H.J.; Lee, H.J.; Ryu, J.Y.; Lee, H.J.; Yoon, E.L.; Lee, S.J.; Hyun, J.J.; Jung, S.W.; Koo, J.S.; Choung, R.S.; Lee, S.W.; Choi, J.H.
- Issue Date
- 2013
- Keywords
- Terlipressin; Necrosis; Hepatorenal syndrome
- Citation
- Clinical and molecular hepatology, v.19, no.4, pp.417 - 420
- Indexed
- SCOPUS
KCI
- Journal Title
- Clinical and molecular hepatology
- Volume
- 19
- Number
- 4
- Start Page
- 417
- End Page
- 420
- ISSN
- 2287-2728
- Abstract
- Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.